Get the Stockscreener App
9.10
0.22%
0.02
After Hours:
3.43
-5.67
-62.31%
Mimedx Group Inc stock is traded at $9.10, with a volume of 1.54M.
It is up +0.22% in the last 24 hours and up +0.44% over the past month.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
See More
Previous Close:
$9.08
Open:
$8.94
24h Volume:
1.54M
Relative Volume:
2.06
Market Cap:
$1.34B
Revenue:
$340.46M
Net Income/Loss:
$98.11M
P/E Ratio:
-52.12
EPS:
-0.1746
Net Cash Flow:
$43.17M
1W Performance:
-0.66%
1M Performance:
+0.44%
6M Performance:
+34.22%
1Y Performance:
+1.68%
1-Day Range:
$8.93
$9.22
1-Week Range:
$8.93
$9.60
52-Week Range:
$5.47
$10.14
Mimedx Group Inc Stock (MDXG) Company Profile
Name
Mimedx Group Inc
Sector
Industry
Phone
(770) 651-9100
Address
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
20.72 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1402 | 295.87M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
MOBBW
Mobilicom Limited Warrants
|
0.6475 | 278.60M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.32 | 142.97M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
4.01 | 52.16M | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-02-24 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-24 | Initiated | Lake Street | Buy |
| Oct-27-23 | Initiated | Craig Hallum | Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-26-21 | Initiated | Northland Capital | Outperform |
| Mar-19-21 | Initiated | H.C. Wainwright | Buy |
View All
Mimedx Group Inc Stock (MDXG) Latest News
MIMEDX Group's SWOT analysis: wound care firm's stock faces market headwinds - Investing.com
MIMEDX Files Patent Infringement Lawsuit Against Surgenex - GlobeNewswire
MiMedx Group (MDXG) Files Patent Infringement Lawsuit Against Surgenex - StreetInsider.com
MIMEDX Battles Patent Infringement: Files Major Lawsuit Over Placental Allograft Technology - StockTitan
MiMedx extends corporate HQ lease, ensures director indemnification - Investing.com
MiMedx extends corporate HQ lease, ensures director indemnification By Investing.com - Investing.com UK
(MDXG) On The My Stocks Page - Stock Traders Daily
EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE P - The Eastern Progress Online
MIMEDX Group's SWOT analysis: wound care firm's stock faces growth hurdles - Investing.com Nigeria
MiMedx Group, Inc. (NASDAQ:MDXG) Stock Holdings Lifted by Charles Schwab Investment Management Inc. - MarketBeat
Amniotic Membrane Market Expected to Reach Huge Growth by 2031 | - openPR
MiMedx Group (NASDAQ:MDXG) shareholder returns have been decent, earning 39% in 3 years - Simply Wall St
Brokerages Set MiMedx Group, Inc. (NASDAQ:MDXG) PT at $12.00 - MarketBeat
MDXG stock soars to 52-week high, touches $9.66 By Investing.com - Investing.com South Africa
How the (MDXG) price action is used to our Advantage - Stock Traders Daily
MDXG stock soars to 52-week high, touches $9.66 - Investing.com India
MIMEDX to Participate in Upcoming Investor Conferences - GlobeNewswire
MIMEDX to Present at Three Major Healthcare Investor Conferences in December - StockTitan
Institutional investors own a significant stake of 43% in MiMedx Group, Inc. (NASDAQ:MDXG) - Yahoo Finance
MiMedx Group Q3 2024 Earnings Preview - MSN
Isthmus Partners LLC Trims Holdings in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
MiMedx Group Stock Soars to 52-Week High of $9.62 By Investing.com - Investing.com South Africa
MiMedx Group Stock Soars to 52-Week High of $9.62 - Investing.com India
MDXG (MiMedx Group) 3-Year Book Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
MDXG (MiMedx Group) Net Income From Continuing Operations : $85.8 Mil (TTM As of Sep. 2024) - GuruFocus.com
Chronic Wound Care Market to Expand at a Modest 4.17% CAGR through 2031 | SkyQuest Technology - Benzinga
MDXG (MiMedx Group) 3-Year Revenue Growth Rate : -1.30% (As of Sep. 2024) - GuruFocus.com
(MDXG) Investment Report - Stock Traders Daily
MDXG (MiMedx Group) Total Liabilities : $62.9 Mil (As of Sep. 2024) - GuruFocus.com
How Much Upside is Left in MiMedx (MDXG)? Wall Street Analysts Think 37.12% - Yahoo Finance
MiMedx Group (NASDAQ:MDXG) Reaches New 1-Year HighHere's Why - MarketBeat
Mizuho increases MiMedx stock target, rating held on Medicare decision - Investing.com
Mizuho increases MiMedx stock target, rating held on Medicare decision By Investing.com - Investing.com Canada
MiMedx stock soars to 52-week high, touches $9.28 - Investing.com India
MiMedx stock soars to 52-week high, touches $9.28 By Investing.com - Investing.com Canada
MiMedx Group (NASDAQ:MDXG) Shares Gap UpShould You Buy? - MarketBeat
MIMEDX’s Advocacy to Rein in Runaway Medicare Spend for - GlobeNewswire
MIMEDX Products Secure Medicare Coverage as 200+ Competitors Cut from 2025 LCD Update | MDXG Stock News - StockTitan
(MDXG) Trading Advice - Stock Traders Daily
Analysts Set MiMedx Group, Inc. (NASDAQ:MDXG) Price Target at $12.00 - MarketBeat
MiMedx Group (NASDAQ:MDXG) Downgraded to Buy Rating by StockNews.com - MarketBeat
Trigran Investments, Inc. Expands Stake in MiMedx Group Inc - GuruFocus.com
MiMedx Group's (NASDAQ:MDXG) Promising Earnings May Rest On Soft Foundations - Yahoo Finance
There's No Escaping MiMedx Group, Inc.'s (NASDAQ:MDXG) Muted Earnings Despite A 27% Share Price Rise - Simply Wall St
Mimedx Group Inc Stock (MDXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mimedx Group Inc Stock (MDXG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hulse William Frank IV | General Counsel and CAO |
Mar 13 '24 |
Sale |
7.95 |
20,381 |
162,029 |
479,959 |
| Whitlow Ricci S | Chief Operating Officer |
Feb 16 '24 |
Sale |
8.07 |
15,493 |
125,075 |
416,321 |
| Whitlow Ricci S | Chief Operating Officer |
Feb 20 '24 |
Sale |
8.01 |
15,271 |
122,351 |
401,050 |
| Whitlow Ricci S | Chief Operating Officer |
Feb 14 '24 |
Sale |
8.03 |
15,845 |
127,267 |
447,012 |
| Whitlow Ricci S | Chief Operating Officer |
Feb 15 '24 |
Sale |
8.06 |
15,198 |
122,496 |
431,814 |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):